VanEck Pharmaceutical ETF
PPH
PPH
51 hedge funds and large institutions have $98.3M invested in VanEck Pharmaceutical ETF in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
45% less capital invested
Capital invested by funds: $177M → $98.3M (-$79.2M)
Holders
51
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$13.1M | |
| 2 | +$4.78M | |
| 3 | +$4.13M | |
| 4 |
CC
Colrain Capital
Boston,
Massachusetts
|
+$2.4M |
| 5 |
Morgan Stanley
New York
|
+$1.43M |
Top Sellers
| 1 | -$65.6M | |
| 2 | -$15.8M | |
| 3 | -$3.7M | |
| 4 |
VF
Virtu Financial
New York
|
-$2.32M |
| 5 |
AL
Aspiriant LLC
Los Angeles,
California
|
-$1.7M |